Evrofarma SA (ATH:EVROF)
3.720
-0.020 (-0.53%)
Oct 22, 2026, 2:51 PM EEST
| Market Cap | 50.83M +40.8% |
| Revenue (ttm) | 51.59M +6.6% |
| Net Income | 4.32M +60.7% |
| EPS | 0.32 +60.7% |
| Shares Out | 13.66M |
| PE Ratio | 11.76 |
| Forward PE | n/a |
| Dividend | 0.06 (1.61%) |
| Ex-Dividend Date | Sep 15, 2026 |
| Volume | 794 |
| Open | 3.630 |
| Previous Close | 3.740 |
| Day's Range | 3.630 - 3.770 |
| 52-Week Range | 2.590 - 4.370 |
| Beta | 0.70 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Sep 25, 2026 |